CompanyGraph
At a glance
- Depends onMidstream position: 8 outgoing, 8 incoming connections
- PositionGross margin is 10.2%, lower than 95% of its Building Products & Equipment peers (median 26.6%)
- FinancialsAltman Z-Score 2.07: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.62BCNY541.16M · vs all stocks (USD)
Revenue (TTM)
1.20BCNY179.02M · vs all stocks (USD)
Profit Margin
-4.23%vs Building Products & Equipment peers
Beta
-0.2220xvs all stocks
52-Week Change
48.28%vs all stocks
Market Capitalization
3.62BCNY541.16M · vs all stocks (USD)
Enterprise Value
3.95BCNY589.15M · vs all stocks (USD)
Price to Sales (TTM)
2.99xvs Building Products & Equipment peers
Price to Book (MRQ)
3.15xvs Building Products & Equipment peers
Enterprise to Revenue
3.29xvs Building Products & Equipment peers
Enterprise to EBITDA
-136.82xvs Building Products & Equipment peers
Gross Margin
10.24%vs Building Products & Equipment peers
Profit Margin
-4.23%vs Building Products & Equipment peers
Operating Margin
7.21%vs Building Products & Equipment peers
Return on Assets (TTM)
-0.87%vs Building Products & Equipment peers
Return on Equity (TTM)
-4.17%vs Building Products & Equipment peers
Revenue (TTM)
1.20BCNY179.02M · vs all stocks (USD)
Revenue per Share (TTM)
6.42CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-23.00%vs Building Products & Equipment peers
Gross Profit (TTM)
156.73MCNY23.40M · vs all stocks (USD)
EBITDA (TTM)
37.75MCNY5.64M · vs all stocks (USD)
Net Income (TTM)
-50.66MCNY-7.56M · vs all stocks (USD)
Operating Cash Flow (TTM)
-89.03MCNY-13.29M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-123.71MCNY-18.47M · vs all stocks (USD)
Payout Ratio
27.59%vs Building Products & Equipment peers
Revenue
1.48BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.28BCNYFY2025 · Dec 31, 2025Gross Profit
205.61MCNYFY2025 · Dec 31, 2025Operating Income
69.12MCNY10.32M · vs all stocks (USD)
Pre-tax Income
-42.50MCNYFY2025 · Dec 31, 2025Income Tax Expense
-7.48MCNYFY2025 · Dec 31, 2025Net Income
-35.02MCNYFY2025 · Dec 31, 2025EBIT
-25.30MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
87.40MCNYFY2025 · Dec 31, 2025Research & Development
69.14MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
22.55MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
953.88KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
17.21MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1900CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1900CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
184.34MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
184.34MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-35.02MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
80.74MCNYFY2025 · Dec 31, 2025Free Cash Flow
71.55MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
118.80MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-35.02MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.97MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
51.16MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
44.64MCNYFY2025 · Dec 31, 2025Capital Expenditures
-9.19MCNYFY2025 · Dec 31, 2025Purchase of Investments
-101.00MCNYFY2025 · Dec 31, 2025Sale of Investments
274.29MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
164.10MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
643.98MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-540.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-31.87MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.48MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
69.12MCNYFY2025 · Dec 31, 2025Shares Outstanding
182.93MSharesUpdated Sep 22, 2026Float Shares
70.07MSharesUpdated Sep 22, 2026% Held by Insiders
66.59%vs all stocks
% Held by Institutions
0.95%vs all stocks
Total Cash (MRQ)
297.69MCNY44.45M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.63CNYUpdated Sep 22, 2026Total Debt (MRQ)
655.66MCNY97.91M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5508xvs Building Products & Equipment peers
Current Ratio (MRQ)
1.55xvs Building Products & Equipment peers
Book Value per Share (MRQ)
6.22CNYUpdated Sep 22, 2026Total Assets
3.13BCNY466.95M · vs all stocks (USD)
Total Current Assets
2.89BCNYFY2025 · Dec 31, 2025Total Liabilities
1.97BCNYFY2025 · Dec 31, 2025Total Non-current Assets
236.04MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.15MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.96BCNYFY2025 · Dec 31, 2025Cash
118.80MCNYFY2025 · Dec 31, 2025Cash Equivalents
7.49MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
126.29MCNYFY2025 · Dec 31, 2025Other Short-term Investments
70.58MCNYFY2025 · Dec 31, 2025Accounts Receivable
749.31MCNYFY2025 · Dec 31, 2025Inventory
33.09MCNYFY2025 · Dec 31, 2025Accounts Payable
1.08BCNYFY2025 · Dec 31, 2025Short-term Debt
634.31MCNYFY2025 · Dec 31, 2025Other Current Liabilities
189.65MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
6.61MCNYFY2025 · Dec 31, 2025Common Stock (Book)
182.93MCNYFY2025 · Dec 31, 2025Retained Earnings
347.13MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.16BCNY173.32M · vs all stocks (USD)
52-Week Low
11.20CNYUpdated Sep 22, 202652-Week High
35.61CNYUpdated Sep 22, 202652-Week Change
48.28%vs all stocks
Beta
-0.2220xvs all stocks
50-Day MA
24.50CNYUpdated Sep 22, 2026200-Day MA
16.68CNYUpdated Sep 22, 2026Avg 10-Day Volume
7.98MSharesUpdated Sep 22, 2026Avg 30-Day Volume
17.79MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.2800CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 10.2%, lower than 95% of its Building Products & Equipment peers (median 26.6%)Significant
Gross margin: 0.10Industry median: 0.27Industry P5: 0.12Peers compared: 84.00
Financial Health
Altman Z-Score 2.07: grey zoneSignificant
Altman Z-Score: 2.07
Low earnings qualitySignificant
Earnings Quality Score: -1.98
Supply Chain
Midstream position: 8 outgoing, 8 incoming connectionsNotable
Outgoing: 8.00Incoming: 8.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Kaili Catalyst & New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Guangdong DP Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Vibhavadi Medical Center Public Company Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Ta-I Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Titan Scientific Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinostar Cable Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Inner Mongolia Ojing Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jiangxi Huawu Brake Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Triductor Technology Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wanma Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Md Entertainment Tbk
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated